Maynard Um
-
-
-
-
-
-
-
Penumbra reports improved outcomes in pulmonary embolism trial
-
-
-
-
-
-
-
Canaccord Genuity Downgrades Penumbra (PEN) to Hold
-
-
-
-
-
-
-
Truist Securities Downgrades Penumbra (PEN) to Hold
-
-
-
-
-
-
-
Penumbra surges on news of $14.5 billion Boston Scientific buyout, BSX down
-
-
-
-
-
-
-
Penumbra (PEN) PT Raised to $312 at Truist Securities
-
-
-
-
-
-
-
Evercore ISI Starts Penumbra (PEN) at Outperform
-
-
-
-
-
-
-
Penumbra stock surges on approval hopes
-
468,575 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


